Agilent Technologies helps City of Daegu and Daegu Gyeongbuk Institute of Science and Technology search for biomarkers for neurological diseases

摘要

Agilent Technologies Inc. (NYSE:A) announced the creation of a new center for neurometabolomics research and training in the city of Daegu. The center will serve as the base for the company's collaboration with the department of brain science at theDaegu Gyeongbuk Institute of Science and Technology (DGIST) and the city.This is Agilent's first collaboration in Asia for metabolomics research in brain science.Metabolomics is the study of the small molecules produced during metabolism -chemical processes in a cell or organism that are necessary for life. Through metabolomics, scientists and researchers are able to discover biomarkers for neurological diseases.